CDC

Latest Issue of OR Manager
April 2021

CDC: Risk of getting COVID-19 from surfaces is low

Editor's Note In a science brief based on the Centers for Disease Control and Prevention’s (CDC’s) analysis of the latest available data, the agency says the risk of getting COVID-19 from surfaces “is generally considered to be low.” The CDC noted that: The risk of COVID-19 infection via surface transmission…

Read More

By: Judy Mathias
April 6, 2021
Share

CDC: Fully vaccinated people are safe for domestic travel

Editor's Note The Centers for Disease Control and Prevention (CDC), on April 2, updated its information for travelers to say people who are fully vaccinated can travel safely within the US. The update notes that fully vaccinated travelers do not have to be tested before or after travel unless required…

Read More

By: Judy Mathias
April 5, 2021
Share

Breathe easier with the right respiratory protection

The COVID-19 pandemic has underscored the importance of respiratory protection in healthcare settings and in the community. Healthcare workers at high risk of infection need the most effective respiratory protection, and not all surgical masks and respirators are alike. Checking for proper fit, donning and doffing correctly, and following manufacturers’…

Read More

By: Judith M. Mathias, MA, RN
March 19, 2021
Share

Sponsored Message

Vaccine hesitancy and variants challenge efforts to tame COVID-19

The Janssen Biotech, Inc/Johnson & Johnson COVID-19 vaccine received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) on February 27, joining the Pfizer-BioNTech and Moderna vaccines that received EUA in December 2020. In early March, President Biden said that the US would produce enough COVID-19 vaccines…

Read More

By: Elizabeth Wood
March 19, 2021
Share

Editorial

This issue of OR Manager is being published just about a year after the nationwide shutdown that was implemented to curb the spread of SARS-CoV-2, the virus that causes COVID-19. Failures on many fronts ensued in the months that followed, with an excessive death toll and unprecedented disruptions in every…

Read More

By: Elizabeth Wood
March 19, 2021
Share

COVID-19 cases, deaths, hospitalizations continue to fall

Editor's Note The number of new COVID-19 cases in the US dropped 12%, deaths fell 18%, and hospitalizations declined 16% last week, the March 8 Reuters reports. At the same time, an average of 2.2 million COVID-19 vaccines were administered each day, up from 1.6 million the week before. Despite…

Read More

By: Judy Mathias
March 10, 2021
Share

Sponsored Message

Effects of mask mandates, opening restaurants on COVID-19 cases, mortality

Editor's Note The Centers for Disease Control and Prevention (CDC) on March 5 released a study showing mask mandates were responsible for a decrease in COVID-19 case growth rates by 0.5% after 20 days and by 1.8% after 100 days. Mask mandates also were associated with a 0.7% decrease in…

Read More

By: Judy Mathias
March 9, 2021
Share

CDC loosens restrictions for fully vaccinated people

Editor's Note The Centers for Disease Control and Prevention (CDC) on March 8 released interim recommendations saying that people who are fully vaccinated against COVID-19 can safely gather with fully vaccinated people from other households without wearing masks or physical distancing. They also can visit indoors with unvaccinated people from…

Read More

By: Judy Mathias
March 9, 2021
Share

Japan supercomputer shows double-masking benefits are limited

Editor's Note A study by the Riken research institute and Kobe University using Fugaku, the world’s fastest supercomputer, finds that wearing two masks offers little benefit in preventing the spread of COVID-19 compared to one well-fitted disposable mask, the March 4 Reuters reports. The researchers found that tightly-fitted surgical masks…

Read More

By: Judy Mathias
March 8, 2021
Share

FDA issues EUA for J&J’s single-dose COVID-19 vaccine

Editor's Note The Food and Drug Administration (FDA) on February 27 issued an emergency use authorization (EUA) for Johnson & Johnson’s single-dose COVID-19 vaccine, making it the third coronavirus vaccine approved for use in the US. The vaccine can be administered to people ages 18 and older. Vaccinations will begin…

Read More

By: Judy Mathias
March 1, 2021
Share

Get OR Manager Updates

Sign Up Now
Video Spotlight
 
OR Manager Jobs
Live chat by BoldChat